Theatre 2: Rehab

Below is the 2019 agenda. The 2020 timetable will be released closer to the event.

Tuesday 26th March

Wednesday 27th March

speaker

11.00 - 11.30

NECHAMA KARMAN

Braking Bad: Developing Eccentric Control in Clients with CNS Dysfunction

Eccentric muscle contractions are the brakes of the movement system. In the normal gait pattern, the majority of muscle contractions are eccentric, yielding remarkable efficiency: harnessing momentum and ground reaction forces, minimizing the energy cost of walking. In individuals with neurological injuries, movement impairments impede the ability to generate eccentric contractions or to time muscle contractions correctly, yielding co-contraction and inefficiency. We will identify how these impairments impede postural control and gait ability and how to specifically address them using voicing as a mechanism to promote eccentric muscle contractions in intervention programs to minimize negative effects on gait and maximize walking performance. Video cases will allow participants to view application of these methods using a variety of therapeutic handling techniques and functional tasks.

speaker

11.45 - 12.15

Dr Vijay Palanivel

Paediatric brain injury: outcomes and predictors of long-term prognosis

Acquired brain injury is the leading cause of death and neurologic disability in children after infancy. In the immature brain, there is a complex interaction between recovery and ongoing development making children more vulnerable than adults despite the advantage of early neuroplasticity. Relatively good motor outcomes may obscure cognitive and behavioural problems, worsening the child’s quality of life and long term educational attainment. Predicting long term outcomes is challenging due to the heterogeneity of injury and non-injury factors.

speaker

12.30 - 13.00

GERAINT THOMAS
SARA DA SILVA RAMOS

Turning the tables in brain injury rehabilitation: Digitalisation and clinical data to inform service development

We will share the journey of the Brain Injury Rehabilitation Trust in developing its rehabilitation services using clinical expertise, data and technology. Come and find out about the tools we’ve used, the challenges we’ve had, and some of our successes in our continuous pursuit to improve our services and support our service users to achieve greater independence and their life goals.

speaker

13.15 - 13.45

Prof. Ioannis Patrikios
Chairman of the School of Medicine
European University Cyprus

Specific Structured Nutritional Molecules as Strong Antiinflammatory Agents for Neuro-degenerative Diseases: True or False

The role of EPA/DHA (omega-3) and LA/GLA (omega-6) Polyunsaturated fatty acids in the Bio-mechanism of inflammation and how synergy with specific natural antioxidants can affect chronic degenerative diseases like MS

speaker

14.00 - 14.30

Eva Sobonova
Sarah Harris
Mary Brady

TBA

Looking at multidisciplinary team working, placing emphasis on holistic and person centred care. Explaining how a service has been re-engineered to integrate goal setting and outcome measures to span of all the disciplines involved. Highlighting the challenges faced, whilst re-modelling a service to take a more MDT approach. Reviewing the before during and after, with an eye firmly on our aspirations for the future – a fully committed multidisciplinary approach.

speaker

14.45 - 15.15

Ali Gibson

Spinal Cord Injury; the unseen complex complications – Neuropathic Pain

Spinal Cord Injury (SCI) results in total or varying degrees of loss of sensation and motor function below the level of injury. These aspects of SCI ‘seen’ by others. However, there are many complex, chronic issues that are ‘unseen’ e.g., neuropathic pain, bladder and bowel function, spasticity, pressure ulcers and urinary tract infections (UTIs). Such complex aspects of SCI often co- exist, fluctuate over time, are unpredictable and are often more debilitating than the ‘seen’ aspects of SCI. This seminar will describe the ‘seen’ and ‘unseen’ complications following SCI using a visual analogy. The negative impact of the ‘unseen’ aspects of SCI on a person’s quality of life will be described. Neuropathic pain will be discussed in more detail.